A Test of Efficacy and Foot Position Alteration in Patients Wearing Good Feet Arch Supports for the Treatment of Pain
Good Feet
1 other identifier
observational
43
1 country
1
Brief Summary
This study is a single armed prospective case series designed to evaluate the efficacy of treating common structural-related foot ailments (i.e. plantar fasciitis, metatarsalgia, and/or hallux valgus) with a high quality non-custom made arch support. It is believed that these conditions are the result of inadequate or poorly fitted arch supports resulting in a lack of structural correction in the foot while weight bearing. Over-the-counter insoles are believed to counteract the shortcomings in foot structure that result in these painful conditions. In this study, it is proposed that changes in foot morphology can be measured quantitatively using weight bearing CT Scan (Computerized Tomography) and X-rays of the subject with and without the arch supports. Subjects will also answer questions from a validated series of questionnaires pertaining to their foot condition and generalized health and activity level. The study is a minimal risk study, with all subjects receiving the arch supports being investigated. There is no placebo offered. Initial evaluation of all subjects will include all imaging and measurements. Collection of subjective responses will occur after 4 weeks, 8 weeks, and 12 weeks of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedFirst Submitted
Initial submission to the registry
July 14, 2025
CompletedFirst Posted
Study publicly available on registry
August 5, 2025
CompletedAugust 8, 2025
August 1, 2025
1.6 years
July 14, 2025
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Reported Outcome Measurement Information System (PROMIS)-Pain Intensity Score
Change in symptoms and relief of pain will be quantified based on subjective completion of validated questionnaires. Scoring is based on a 5-point scale, with higher scores indicating greater pain intensity. Raw scores are converted to T-scores, standardized to a mean of 50 (average for the general population) and a standard deviation of 10. Higher T-scores reflect more severe pain intensity.
12 weeks
Patient Reported Outcome Measurement Information System (PROMIS)-Pain Interference Score
PROMIS Pain Interference measures the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. Respondents rate how much pain has interfered with their daily life over the past 7 days. Scoring uses a 5-point scale, with higher scores indicating greater interference. Raw scores are converted to T-scores (mean = 50, SD = 10); higher T-scores represent more significant pain interference.
12 weeks
Secondary Outcomes (3)
Change in foot morphology- Weightbearing X-ray
Baseline
Change in foot morphology- Weightbearing CT scans
Baseline
Patient Reported Outcome Measurement Information System (PROMIS)-Global Health
12 weeks
Study Arms (1)
Inclusion 1. Men or women ≥ 18 and ≤ 65 years of age 2. The subject is able and willing to comply w
Subjects with foot pain who are able to wear arch supports.
Interventions
Set of 3 arch supports supplied by Good Feet
Eligibility Criteria
Subjects will be recruited from the clinicians in the Division of Podiatry under the Department of Orthopaedics. Additionally, the sponsor, Good Feet Worldwide has a trade store the MGH service area, and will allow us to promote the study at their location with an advertisement poster. Potential subjects from the trade store will be referred to our clinics for screening and, when appropriate, recruited for the study.
You may qualify if:
- Men or women ≥ 18 and ≤ 65 years of age
- Able and willing to comply with study procedures, and a signed and dated
- Diagnosed with symptomatic hallux valgus and/or plantar fasciitis and/or metatarsalgia
- Has had foot pain for at least 30 days
- Willing and able to utilize insole when walking for 90 days
- BMI ≤ 35
- Able to walk up to 0.5 miles without difficulty in a 24-hour period
You may not qualify if:
- Inability or unwillingness to comply with study procedures
- Gross asymmetry in feet, where shoe size differs by 2 or more full sizes between right and left foot
- Subject has had a CT performed within the last 30 days, for any body part.
- Prior partial or total amputation of a foot
- BMI \> 35.
- Unilateral or bilateral foot deformity that would hinder the fitting of an over-the-counter arch support, such as active Charcot foot or Charcot with boney prominence
- Ulcers or open sores on either foot
- Currently wearing custom shoes or insoles.
- Currently ambulating with a cane, crutches, walker.
- Currently using any type of foot or ankle brace, and/or having used a brace in the last 30 days.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam S Landsman, DPM, PhD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 14, 2025
First Posted
August 5, 2025
Study Start
June 13, 2022
Primary Completion
December 31, 2023
Study Completion
March 31, 2024
Last Updated
August 8, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
HIPPA compliance